|
| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 14262.59 | 14252.47 | 13982.69 |
| 60日平均 | 120日平均 | 260日平均 |
| 13439.42 | 12980.08 | 11575.06 |
| Date | Price | Change% |
| 2026/01/22 | 14327.045 | 0.50% |
| 2026/01/21 | 14255.125 | 0.70% |
| 2026/01/20 | 14155.628 | -0.97% |
| 2026/01/19 | 14294.053 | 0.09% |
| 2026/01/16 | 14281.08 | -0.18% |
| 2026/01/15 | 14306.726 | 0.41% |
| 2026/01/14 | 14248.599 | 0.56% |
| 2026/01/13 | 14169.397 | -1.37% |
| 2026/01/12 | 14366.908 | 1.75% |
| 2026/01/09 | 14120.151 | 1.15% |
| 2026/01/08 | 13959.482 | -0.51% |
| 2026/01/07 | 14030.559 | 0.06% |
| 2026/01/06 | 14022.552 | 1.40% |
| 2026/01/05 | 13828.63 | 2.24% |
| 2025/12/31 | 13525.022 | -0.58% |
| 2025/12/30 | 13604.067 | 0.49% |
| 2025/12/29 | 13537.097 | -0.49% |
| 2025/12/26 | 13603.894 | 0.54% |
| 2025/12/25 | 13531.411 | 0.33% |
| 2025/12/24 | 13486.419 | 0.88% |
相關基金績效 (可點按欄位名稱排序)
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 深證成指 | 9.17% | 6.76% | 26.43% | 4.78% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | 11.10% | 34.82% | 32.26% | 4.74% |
| 聯博中國A股基金-A2類型/美元 | 7.82% | 25.42% | 37.06% | 4.13% |
| 聯博中國A股基金-A2類型/人民幣 | 5.37% | 21.57% | 30.80% | 3.74% |
| 富達中國聚焦基金/美元 | 0.44% | 7.17% | 30.54% | 3.11% |
| 法巴中國股票基金-C股/美元 | 18.77% | 22.80% | 31.79% | 18.92% |
| 安聯中國策略基金/台幣 | 13.16% | 42.19% | 35.44% | 4.06% |
| 安聯中國股票基金-A股/配息/美元 | -1.54% | 10.64% | 35.66% | 4.43% |
| 霸菱香港中國基金-A類/配息/歐元 | 2.33% | 12.30% | 19.56% | 6.22% |
| 霸菱香港中國基金-A類/配息/美元 | 3.16% | 12.95% | 35.26% | 5.91% |
| 霸菱香港中國基金-A類/配息/英鎊 | 2.97% | 13.37% | 23.42% | 6.28% |
| 貝萊德中國基金A2/美元 | 1.51% | 8.95% | 30.15% | 4.77% |
| 貝萊德中國基金A2-歐元避險 | 0.91% | 7.49% | 26.55% | 4.59% |
| 貝萊德中國基金A2-澳幣避險 | 1.37% | 8.38% | 27.63% | 4.72% |
| 群益華夏盛世基金/台幣 | 10.15% | 29.67% | 23.70% | 3.69% |
| 群益華夏盛世基金/美元 | 6.87% | 20.58% | 28.13% | 3.05% |
| 群益華夏盛世基金/人民幣 | 4.48% | 16.94% | 22.48% | 2.61% |
| 群益中國新機會基金/台幣 | 9.56% | 27.17% | 20.58% | 4.49% |
| 群益中國新機會基金/美元 | 6.34% | 18.29% | 25.05% | 3.94% |
| 群益中國新機會基金/人民幣 | 3.97% | 14.72% | 19.53% | 3.49% |
| DWS投資中國股票基金E2/美元 | 3.65% | 17.91% | 23.93% | 15.77% |
| DWS投資中國股票基金A2/美元 | 14.96% | 19.61% | 24.27% | 15.09% |
| DWS投資中國股票基金FC/歐元 | -2.39% | 3.13% | 13.75% | 2.31% |
| DWS投資中國股票基金LC/歐元 | 8.52% | 5.45% | 15.14% | 2.42% |
| 瀚亞中國基金/台幣 | 10.07% | 41.79% | 46.38% | 6.46% |
| 瀚亞中國股票基金/美元 | 3.50% | 13.89% | 42.14% | 3.35% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | -1.76% | 3.10% | 23.33% | 2.06% |
| 愛德蒙得洛希爾中國基金(A)/美元 | 3.84% | 17.76% | 34.15% | 15.82% |
| 歐義銳榮中國股票基金-R/歐元 | -0.69% | 7.18% | 17.14% | 2.82% |
| 歐義銳榮中國股票基金-R2/美元 | -0.06% | 7.92% | 32.09% | 2.68% |
| 首域盈信中國核心基金/美元 | 9.16% | 12.40% | 18.57% | 6.94% |
| 富蘭克林華美中國消費基金/台幣 | 7.83% | 23.30% | 16.04% | 3.35% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | 10.13% | 26.09% | 16.26% | 4.71% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | 4.30% | 13.84% | 15.41% | 3.83% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | 6.77% | 17.23% | 20.49% | 4.00% |
| 復華華人世紀基金/台幣 | 27.09% | 58.23% | 76.89% | 11.37% |
| 復華大中華中小策略基金/台幣 | 17.18% | 40.45% | 26.76% | 3.47% |
| 匯豐中國動力基金-台幣 | 17.29% | 41.66% | 44.04% | 8.51% |
| 匯豐中國股票基金AD/美元 | 13.70% | 18.83% | 17.02% | 13.93% |
| 景順中國基金-A股/美元 | 1.37% | 11.83% | 32.48% | 4.91% |
| 景順中國基金-A股/歐元對沖 | 0.84% | 10.33% | 29.72% | 4.80% |
| 景順中國基金-A股/澳幣對沖 | 1.12% | 11.17% | 30.57% | 4.83% |
| 摩根中國基金-A股/分派/美元 | 0.55% | 12.36% | 32.22% | 3.05% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 13.43% | 16.64% | 37.41% | 13.75% |
| 野村中國機會基金/台幣 | 16.18% | 34.44% | 34.44% | 9.03% |
| 鋒裕匯理-中國股票基金-A2/美元 | 4.07% | 17.28% | 24.44% | 15.57% |
| 鋒裕匯理-中國股票基金-B2/美元 | 3.90% | 16.86% | 23.56% | 15.21% |
| 鋒裕匯理-中國股票基金-A2/歐元 | -1.77% | 2.48% | 14.18% | 1.67% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | 9.38% | 25.75% | 18.20% | 17.32% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | -2.56% | 5.26% | 31.08% | 1.70% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | -3.04% | 4.23% | 28.53% | 1.54% |
| 元大新中國基金/台幣 | 9.10% | 28.09% | 17.09% | 4.44% |
| ( 中國基金 ) | 5.31% | 16.19% | 23.80% | 4.85% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|